Compounds > landiolol
Page last updated: 2024-09-02

landiolol and Takotsubo Cardiomyopathy

landiolol has been researched along with Takotsubo Cardiomyopathy in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Cho, Y; Inoue, K; Kunimoto, M; Minamino, T1
Arakawa, S; Kawano, H; Maemura, K; Matsumoto, Y; Sato, O; Yamasa, T2
Madias, JE1

Other Studies

4 other study(ies) available for landiolol and Takotsubo Cardiomyopathy

ArticleYear
Haemodynamic effects of acute intravenous landiolol in Takotsubo cardiomyopathy with dynamic left ventricular outflow tract obstruction.
    BMJ case reports, 2023, Oct-16, Volume: 16, Issue:10

    Topics: Cardiomyopathy, Hypertrophic; Hemodynamics; Humans; Mitral Valve; Mitral Valve Insufficiency; Takotsubo Cardiomyopathy; Ventricular Outflow Obstruction; Ventricular Outflow Obstruction, Left

2023
Landiolol dramatically improved Takotsubo cardiomyopathy in an older patient.
    Geriatrics & gerontology international, 2017, Volume: 17, Issue:12

    Topics: Aged; Humans; Morpholines; Takotsubo Cardiomyopathy; Treatment Outcome; Urea

2017
Cardioselective ultra-short-acting β-blockers for patients with Takotsubo syndrome?
    Geriatrics & gerontology international, 2018, Volume: 18, Issue:5

    Topics: Adrenergic beta-1 Receptor Antagonists; Humans; Morpholines; Takotsubo Cardiomyopathy; Urea

2018
We need more useful surrogate markers for the efficacy of beta-blockers for the treatment of Takotsubo cardiomyopathy.
    Geriatrics & gerontology international, 2018, Volume: 18, Issue:5

    Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Female; Humans; Infusions, Intravenous; Morpholines; Natriuretic Peptide, Brain; Prognosis; Recovery of Function; Takotsubo Cardiomyopathy; Treatment Outcome; Troponin I; Urea

2018